Suppr超能文献

治疗 COVID-19 患者的住院费用。

Inpatient Costs of Treating Patients With COVID-19.

机构信息

RAND Corporation, Arlington, Virginia.

Department of Population Health, Dell Medical School, The University of Texas at Austin.

出版信息

JAMA Netw Open. 2024 Jan 2;7(1):e2350145. doi: 10.1001/jamanetworkopen.2023.50145.

Abstract

IMPORTANCE

With more than 6.2 million hospitalizations due to COVID-19 in the US, recognition of the average hospital costs to provide inpatient care during the pandemic is necessary to understanding the national medical resource use and improving public health readiness and related policies.

OBJECTIVE

To examine the mean cost to provide inpatient care to treat COVID-19 and how it varied through the pandemic waves and by important sociodemographic patient characteristics.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used inpatient-level data from March 1, 2020, to March 31, 2022, extracted from a repository of clinical, administrative, and financial information covering 97% of academic medical centers across the US.

MAIN OUTCOMES AND MEASURES

Cost to produce care for each stay was calculated using direct hospital costs to provide care adjusted for geographic differences in labor costs using area wage indices.

RESULTS

The sample included 1 333 404 stays with a primary or secondary COVID-19 diagnosis from 841 hospitals. The cohort included 692 550 (52%) men, with mean (SD) age of 59.2 (17.5) years. The adjusted mean cost of an inpatient stay was $11 275 (95% CI, $11 252-$11 297) overall, increasing from $10 394 (95% CI, $10 228-$10 559) at the end of March 2020 to $13 072 (95% CI, $12 528-$13 617) by the end of March 2022. Patients with specific comorbidities had significantly higher mean costs than their counterparts: those with obesity incurred an additional $2924 in inpatient stay costs, and those with coagulation deficiency incurred an additional $3017 in inpatient stay costs. Stays during which the patient required extracorporeal membrane oxygenation (ECMO) had an adjusted mean cost of $36 484 (95% CI, $34 685-$38 284).

CONCLUSIONS AND RELEVANCE

In this cross-sectional study, an adjusted mean hospital cost to provide care for patients with COVID-19 increased more than 5 times the rate of medical inflation overall. This appeared to be explained partly by changes in the use of ECMO, which increased over time.

摘要

重要性

在美国,因 COVID-19 而住院的人数超过 620 万,因此,为了解国家医疗资源的使用情况并改善公共卫生准备和相关政策,有必要认识到大流行期间提供住院治疗的平均医院成本。

目的

检查治疗 COVID-19 提供住院护理的平均成本,以及它如何随大流行波和重要的社会人口学患者特征而变化。

设计、地点和参与者:这项横断面研究使用了 2020 年 3 月 1 日至 2022 年 3 月 31 日从美国学术医疗中心临床、行政和财务信息库中提取的住院患者水平数据。

主要结果和措施

使用调整后的区域工资指数,根据劳动力成本的地理差异,对提供护理的直接医院成本进行调整,计算每次住院的护理成本。

结果

样本包括 841 家医院的 1333404 例主要或次要 COVID-19 诊断的住院患者。该队列包括 692550 名(52%)男性,平均(标准差)年龄为 59.2(17.5)岁。总体而言,住院患者的调整后平均费用为 11275 美元(95%置信区间,11252-11297),从 2020 年 3 月底的 10394 美元(95%置信区间,10228-10559)增加到 2022 年 3 月底的 13072 美元(95%置信区间,12528-13617)。有特定合并症的患者的平均费用明显高于其对应患者:肥胖患者的住院费用增加了 2924 美元,凝血功能障碍患者的住院费用增加了 3017 美元。需要体外膜肺氧合(ECMO)的患者的调整后平均费用为 36484 美元(95%置信区间,34685-38284)。

结论和相关性

在这项横断面研究中,为治疗 COVID-19 患者提供护理的调整后平均医院成本增加了 5 倍以上,超过了医疗通胀的总体速度。这似乎部分是由于 ECMO 使用率的变化造成的,随着时间的推移,ECMO 的使用率有所增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c4f/10765267/c294e6131da0/jamanetwopen-e2350145-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验